β€” 01 / Company

One commercial wedge for six frontier programs.

Planckchron is building HERA Nexus as the near-term entry point for an evidence-led architecture spanning emerging compute, biotechnology, autonomous systems, resilient communications, and aerospace research.

One company thesisAccountable intelligence and evidence for frontier systems
One commercial wedgeHERA Nexus concentrates near-term execution
Six product programsEvery product remains behind a defined evidence gate
No inflated readinessTargets remain separate from validated results

Competitive posture

Partner with domain leaders. Build the accountable operating layer.

Planckchron is not publicly representing itself as a scaled foundation-model company, fabricated quantum-hardware manufacturer, clinical-stage drug company, operational communications network, or flight-ready aerospace company. Its thesis is that reusable intelligence, evidence, governance, and human-control patterns can compound across those domains.

See the architecture

Corporate record

Small enough to focus. Structured to compound.

The company is early-stage and pre-revenue unless documentary evidence supports a later update. Public product pages describe research direction, design work, and prototype objectivesβ€”not independently validated commercial performance unless expressly stated.

Founded

2018

Incorporated

2025-08-13

Entity

Delaware C-Corporation

Headquarters

Los Angeles, California

Office

Albuquerque, New Mexico

Stage

Founder-led, early-stage and pre-revenue

Build with us

Bring one consequential workflow and a willingness to measure failure.

Planckchron is seeking design partners, technical reviewers, strategic investors, and government collaborators with a real operating boundary, accountable owner, defined evidence plan, and practical milestone.